Amarin Corporation plc announced that to support the commercialization of VAZKEPA in Greece, Company has entered into an exclusive agreement with Vianex S.A., one of the leading pharmaceutical companies in Greece celebrating its 100-year anniversary this year. Under the terms of the agreement, Vianex S.A. will be the sole and exclusive distributor of VAZKEPA® in the territory to import, register, distribute and commercialize the product. Amarin will be responsible for supplying finished product to Vianex at a transfer price paid to Amarin.

Vianex will start commercializing VAZKEPA® in the course of the next weeks.